LYON, France, June 19, 2025--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases ...

Poxel SA: New Scientific Presentations by Key Opinion Leaders to Further Highlight the Therapeutic Potential of Imeglimin at ADA 2025, the Leading Diabetes Conference Regulatory News: POXEL SA ...

Faculty and students from the Department of Animal Science earned top national honors during American Meat Science Association Conference ...

Structure Therapeutics Inc. announced two late-breaking poster presentations for the upcoming American Diabetes Association 85th Scientific Sessions, focusing on their novel oral small molecule ...

Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering ...

The Sharjah Institute for Heritage (SIH) has wrapped up its Second Heritage Conference, held at the Arab Heritage Center in ...

Thomas Kuhn, CEO of Poxel, stated: "We are very pleased to see that the potential of Imeglimin (TWYMEEG®) in the fight against type 2 diabetes and its associated conditions continues to generate ...

General Nguyen Tan Cuong, Chief of the General Staff (GS) of the Vietnam People s Army and Deputy Defense Minister, chaired a ...

MBX Biosciences will present findings on MBX 1416 at the American Diabetes Association’s Scientific Sessions from June 20-23, 2025. MBX Biosciences, Inc., a biopharmaceutical company ...

GAINESVILLE, Fla. (WCJB) -More than 150 science teachers from across Florida and the Southeast are in Gainesville this week ...

The day-long event aimed to promote dialogue, collaboration, and awareness around citizen-led scientific initiatives, both in ...

The ADA Scientific Sessions is a globally recognized conference dedicated to advancing the field of diabetes. This annual meeting serves as a critical forum for presenting cutting-edge research, ...